BioCryst Pharmaceuticals Balance Sheet Analysis

Assets, liabilities, and stockholders equity in billions USD

Scroll to see more
Balance sheet showing assets, liabilities, and shareholders' equity for BioCryst Pharmaceuticals, Inc. (BCRX) - Annual data in billions USD
BreakdownFY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018
Period EndingDec 2024Dec 2023Dec 2022Dec 2021Dec 2020Dec 2019Dec 2018
Current Assets
Cash and Cash Equivalents0.100.110.420.500.300.140.10
Short-Term Investments0.220.280.120.000.030.000.00
Cash & Short-Term Investments0.320.390.420.510.300.140.10
Accounts Receivable0.080.060.050.030.010.020.00
Inventory0.010.030.030.020.010.000.00
Other Current Assets0.010.020.010.010.010.010.00
Total Current Assets0.420.500.520.570.320.160.11
Non-Current Assets
Property, Plant & Equipment (Net)0.020.020.010.020.010.010.01
Long-Term Investments0.020.000.020.010.000.000.00
Other Non-Current Assets0.030.000.010.010.000.000.00
Total Non-Current Assets0.070.020.030.020.010.010.03
Total Assets0.490.520.550.590.330.180.15
Current Liabilities
Accounts Payable0.010.020.100.030.070.050.03
Short-Term Debt0.030.020.000.000.030.000.00
Current Portion of Long-Term Debt0.030.020.000.000.030.000.00
Accrued Liabilities0.110.020.090.070.060.000.00
Deferred Revenue0.000.000.000.000.000.000.00
Other Current Liabilities0.030.020.020.020.120.000.00
Total Current Liabilities0.160.150.110.100.230.130.07
Non-Current Liabilities
Long-Term Debt0.800.810.240.590.120.000.03
Other Non-Current Liabilities0.000.530.500.450.120.000.00
Total Non-Current Liabilities0.810.820.740.590.120.000.03
Total Liabilities0.970.970.840.700.350.140.10
Stockholders' Equity
Common Stock0.000.000.000.000.000.000.00
Retained Earnings-1.77-1.68-1.45-1.21-1.02-0.84-0.73
Accumulated Other Comprehensive Income0.000.000.000.000.000.000.00
Additional Paid-in Capital1.291.221.161.101.000.880.78
Shares Outstanding0.210.210.190.180.000.000.00
Total Stockholders' Equity-0.48-0.46-0.29-0.11-0.020.040.05
Total Liabilities & Equity0.490.520.550.590.330.180.15